People

Randall F. Holcombe, MD, became director of the University of Hawaii Cancer Center in Honolulu, effective October 3. He replaces Jerris R. Hedges, MD, who had been serving as interim director.

Previously, Holcombe served as the chief medical officer for cancer for the Mount Sinai Health System, deputy director of the NCI-designated Tisch Cancer Institute, and director of ambulatory oncology services at Mount Sinai Hospital, all in New York, NY. Prior to joining Mount Sinai, he served as the division chief of hematology/oncology at the University of California, Irvine.

Holcombe studies the science of healthcare delivery, including the development of tools to measure coordination of patient care and other patient-reported outcomes, and researches disparities in the outcomes of cancer treatment. He has also directed clinical trials related to gastrointestinal cancer.

Brian D. Kavanagh, MD, MPH, chair of the Department of Radiation Oncology at the University of Colorado School of Medicine in Denver, began a 1-year term as president of the American Society for Radiation Oncology (ASTRO) at the organization's annual meeting in September. He succeeds David C. Beyer, MD.

An active clinician, Kavanagh has a keen interest in stereotactic radiosurgery for brain tumors and stereotactic body radiation therapy for other types of tumors. His research aims to enhance the effectiveness of radiotherapy by blocking the action of macrophages that stimulate tumor regrowth after treatment.

Kavanagh has served on several ASTRO committees, including its Stereotactic Radiosurgery Registry and its Board of Directors. He has also served on advisory panels for the Center of Medicare and Medicaid Services, and as a member of the National Comprehensive Cancer Network's Policy Advisory Group.

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.